Skip to content
rawlaw unfiltered legal news
  • News
  • Services for Advocates
  • Bookmarks
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com

restrained

Home - restrained

Delhi High Court grants injunction to GlaxoSmithKline against ‘FEXIT’ marks — “Phonetic similarity in medicines demands stricter scrutiny”; Zee Laboratories restrained
Posted inNews

Delhi High Court grants injunction to GlaxoSmithKline against ‘FEXIT’ marks — “Phonetic similarity in medicines demands stricter scrutiny”; Zee Laboratories restrained

Court’s decision The Delhi High Court granted an interim injunction in favour of GlaxoSmithKline Pharmaceuticals Ltd., restraining Zee Laboratories Limited from using the marks “FEXIT”, “FEXIT-B” and “FEXIT-M” for pharmaceutical…
Posted by Rawlaw March 3, 2026

Recent News

  • Delhi High Court holds AIIMS cannot deny super-speciality admission despite 1095-day tenure — “Post-MD senior residency must be counted”; appeal dismissed on last date of admission
  • Supreme Court of India clarifies surety liability under contract law — “Discharge under Section 133 is only for transactions after variance”; guarantors liable up to sanctioned limit
  • Delhi High Court allows Britannia to amend plaint and implead trademark proprietor — “Perjury requires deliberate falsehood, not inadvertent error”; criminal plea dismissed
  • Delhi High Court refuses injunction against ‘Baby Forest’ — “Forest Essentials is a composite mark; no monopoly over ‘forest’”; appeal dismissed
  • Delhi High Court grants injunction to GlaxoSmithKline against ‘FEXIT’ marks — “Phonetic similarity in medicines demands stricter scrutiny”; Zee Laboratories restrained
Copyright 2026 — Raw Law. All rights reserved.
Scroll to Top